» Articles » PMID: 29296509

Amino Acid and Small GTPase Regulation of MTORC1

Overview
Journal Cell Logist
Date 2018 Jan 4
PMID 29296509
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

The mammalian target of rapamycin (mTOR) is an evolutionarily conserved serine/threonine kinase that belongs to the phosphatidylinositol 3-kinase-related kinase (PIKK) family. mTOR is the catalytic subunit of mTOR complex 1 (mTORC1), which integrates multiple environmental signals to control cell growth and metabolism. Nutrients, specifically amino acids, are the most potent stimuli for mTORC1 activation. Multiple studies have focused on how leucine and arginine activate mTORC1 through the Rag GTPases, with mechanistic details slowly emerging. Recently, a Rag GTPase-independent glutamine signaling pathway to mTORC1 has been identified, suggesting that mTORC1 is differentially regulated through distinct pathways by specific amino acids. In this review, we summarize our current understanding of how amino acids modulate mTORC1, and the role of other small GTPases in the regulation of mTORC1 activity.

Citing Articles

Arf1 promotes porcine intestinal epithelial cell proliferation via the mTORC1 signaling pathway.

Fang Y, Lu E, Xu E, Zhang Y, Zhu M In Vitro Cell Dev Biol Anim. 2024; 60(9):1009-1020.

PMID: 39093368 DOI: 10.1007/s11626-024-00942-y.


Contaminants from dredged sediments alter the transcriptome of Manila clam and induce shifts in microbiota composition.

Bernardini I, Quagliariello A, Peruzza L, Martino M, Dalla Rovere G, Iori S BMC Biol. 2023; 21(1):234.

PMID: 37880625 PMC: 10601118. DOI: 10.1186/s12915-023-01741-9.


Inhibition of phosphodiesterase 4D suppresses mTORC1 signaling and pancreatic cancer growth.

Jeong M, Urquhart G, Lewis C, Chi Z, Jewell J JCI Insight. 2023; 8(13).

PMID: 37427586 PMC: 10371348. DOI: 10.1172/jci.insight.158098.


Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy.

Huan J, Grivas P, Birch J, Hansel D Cancers (Basel). 2022; 14(6).

PMID: 35326708 PMC: 8946148. DOI: 10.3390/cancers14061555.


mTOR-Mediated Regulation of Immune Responses in Cancer and Tumor Microenvironment.

Mafi S, Mansoori B, Taeb S, Sadeghi H, Abbasi R, Cho W Front Immunol. 2022; 12:774103.

PMID: 35250965 PMC: 8894239. DOI: 10.3389/fimmu.2021.774103.


References
1.
Yan G, Lai Y, Jiang Y . The TOR complex 1 is a direct target of Rho1 GTPase. Mol Cell. 2012; 45(6):743-53. PMC: 3334367. DOI: 10.1016/j.molcel.2012.01.028. View

2.
Demetriades C, Doumpas N, Teleman A . Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2. Cell. 2014; 156(4):786-99. PMC: 4346203. DOI: 10.1016/j.cell.2014.01.024. View

3.
Heitman J, Movva N, Hall M . Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science. 1991; 253(5022):905-9. DOI: 10.1126/science.1715094. View

4.
Nakashima S, Morinaka K, Koyama S, Ikeda M, Kishida M, Okawa K . Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors. EMBO J. 1999; 18(13):3629-42. PMC: 1171441. DOI: 10.1093/emboj/18.13.3629. View

5.
Peng M, Yin N, Li M . Sestrins function as guanine nucleotide dissociation inhibitors for Rag GTPases to control mTORC1 signaling. Cell. 2014; 159(1):122-133. PMC: 4181352. DOI: 10.1016/j.cell.2014.08.038. View